NA-R-ALA

product on market Capsule SAN Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for NA-R-ALA
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
60
Servings
Non-Nutrient/Non-Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

100 mg
Market median: 200.0mg (198 products) 6 studies — no high-quality reviews

Other Ingredients

Microcrystalline Cellulose Gelatin Silicon Dioxide Magnesium Stearate Titanium Dioxide FD&C Blue #2
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Recommended Use: As a dietary supplement, take 1 capsule with meals 2-3 times daily.

Warnings & Precautions

Keep away from local space heat sources such as space heaters and radiators. Do not expose to direct sunlight or leave in vehicle exposed to sunlight. Do not allow exposure to high humidity (above 65%).

Manufactured in a facility that also processes egg, shellfish, fish, soy, peanuts, tree nuts and milk ingredients.

Formulation Notes

Description: SAN's stabilized NA-R-ALA contains the worlds first form of NA-R-ALA, the sodium salt of R-Lipoic Acid (RLA).

Note: SAN's NA-R-ALA is stabilized with Na (Sodium). One serving contains less than 1% of the daily value for sodium, an insignificant contribution to dietary sources and therefore not listed on the label. The sodium content is SAN's NA-R-ALA will not affect blood pressure levels.

Biosolv Enhanced & Stable R-Lipoic Acid 125mg NA-R-ALA

Additional Information

Storage Instructions: Protect from heat and freezing. Keep away from local space heat sources such as space heaters and radiators. Do not expose to direct sunlight or leave in vehicle exposed to sunlight. Do not allow exposure to high humidity (above 65%). Keep container tightly closed when not in use.

SAN products are manufactured under GMP (Good Manufacturing Practices) standards with stringent quality control guidelines. Additionally, each lot produced by SAN is independently tested for purity and potency by HPLC analysis to ensure only the highest quality ingredients in our innovative formulas.

Live a vibrant life!

80% purity

Plus enhanced delivery 60 full dosage servings

GMP Certified GMP Manufactured NSF Audited Facility

HPLC & FTIR Tested Quality Approved

Ver 2

Made in the U.S.A.

Metadata

Product Details

UPC / SKU6 72898 15001 5
DSLD Entry Date2018-04-25
Product TypeNon-Nutrient/Non-Botanical
FormCapsule
BrandSAN
DSLD ID175453
Data Updated2026-04-11
Research

Research Evidence

21
Research Sources
52
Avg Quality
13
Rct
4
Meta Analysis
2
Systematic Review
2
Clinical Trial
A Alpha-lipoic acid for diabetic peripheral neuropathy
Systematic Review The Cochrane database of systematic reviews 2024 PubMed DOI
B Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy
Rct Nutrients 2024 PubMed DOI
B Alpha Lipoic Acid Supplementation and Iron Homeostasis: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Meta Analysis International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition 2024 PubMed DOI
B Effectiveness of alpha-lipoic acid in patients with neuropathic pain associated with type I and type II diabetes mellitus: A systematic review and meta-analysis
Meta Analysis Medicine 2023 PubMed DOI
C The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Metabolism: clinical and experimental 2018 PubMed DOI
C A systematic review and meta-analysis of α-lipoic acid in the treatment of diabetic peripheral neuropathy
Meta Analysis European journal of endocrinology 2012 PubMed DOI
C Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study
Rct Endocrine, metabolic & immune disorders drug targets 2020 PubMed DOI
C A randomized, double-blind, placebo controlled study to evaluate the effect of alpha-lipoic acid on inhibition of ADP-and collagen-induced platelet aggregation ex vivo in diabetic neuropathy patients on gabapentin or pregabalin
Rct Journal of postgraduate medicine 2024 PubMed DOI
C Ranking Alpha Lipoic Acid and Gamma Linolenic Acid in Terms of Efficacy and Safety in the Management of Adults With Diabetic Peripheral Neuropathy: A Systematic Review and Network Meta-analysis
Systematic Review Canadian journal of diabetes 2024 PubMed DOI
C Effect analysis of tanshinone IIA sulfonate sodium combined with a-lipoic acid in patients with diabetes peripheral neuropathy.
Rct Pakistan journal of pharmaceutical sciences PubMed
View all evidence for Alpha Lipoic Acid →
Compare

Similar Products

View all Alpha Lipoic Acid products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.